Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats

Journal of the American College of Cardiology

Volumn 29, Issue 4, 1997, Pages 856-861

  Khaper, Neelam ^a   Singal, Pawan K ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CAPTOPRIL; CATALASE; GLUTATHIONE PEROXIDASE; PRAZOSIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; HEART AFTERLOAD; HEMODYNAMICS; LIPID PEROXIDATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CAPTOPRIL; CATALASE; GLUTATHIONE PEROXIDASE; HEART; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATIVE STRESS; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0030993961     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00574-8     Document Type: Article

References (37)

1. Bing RJ. The biochemical basis of myocardial failure. Hosp Pract Off Ed 1983;18:93-7, 101-7, 110-2.
2. Gwathmey JK, Capelas L, Mackinnon R, et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 61:1987;70-76.
3. Hill M, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol. 148:1996;291-300.
4. Dhalla AK, Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol. 266:1994;H1280-5.
5. Gupta M, Singal PK. Higher antioxidant capacity during chronic stable heart hypertrophy. Circ Res. 64:1989;398-406.
6. Gupta M, Singal PK. Time course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol. 67:1989;1549-1559.
7. Dhalla AK, Hill M, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol. 28:1996;506-514.
8. Sobotka PA, Brottman MD, Weitz Z, Birnbaum AJ, Skosey JL, Zarling EJ. Elevated breath pentane in heart failure reduced by free radical scavenger. Free Rad Biol Med. 14:1993;643-647.
9. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 57:1985;84-95.
10. Pfeffer MA, Pfeffer JM, Steinberg C, Jinn P. Survival after an experimental myocardial infarction beneficial effects of long-term therapy with captopril . Circulation. 72:1985;406-412.
11. Jugdutt BI, Schwarz-Michorowski BL, Khan MI. Effects of long-term captopril therapy on left ventricular remodelling and function during healing in canine myocardial infarction. J Am Coll Cardiol. 19:1992;713-721.
12. Miller RR, Awan NA, Maxwell KS, Mason DT. Sustained reduction of cardiac impedence and preload in congestive heart failure with the antihypertensive vasodilator prazosin. N Engl J Med. 297:1977;303-307.
13. Awan NA, Miller RR, DeMaria AN, Maxwell KS, Newman A, Mason DT. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography . Circulation. 56:1977;346-354.
14. Chatterjee K, Parmley WW, Ganz W, et al. Hemodynamics and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation. 48:1973;1183-1187.
15. Cohn JN, Archibald DG, Ziesche S, et al. Effects of vasodilator therapy on mortality in chronic congestive heart failure results of a Veterans Administration Cooperative Study . N Engl J Med. 314:1986;1547-1552.
16. Selye H, Bajusz E, Grasso S, Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology. 11:1960;398-407.
17. Dixon IMC, Hata T, Dhalla NS. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol. 262:1992;H1387-94.
18. Marklund SL. Pyrogallol autooxidation. Greenwald RA. Handbook of Methods for Oxygen Radical Research. 1985;243-247 CRC Press, Boca Raton (FL).
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 70:1967;158-169.
20. Clairborne A. Catalase activity. Greenwald RA. Handbook of Methods for Oxygen Radical Research. 1985;283-284 CRC Press, Boca Raton (FL).
21. 2+-binding and lipid peroxidation but depresses myocardial function. Am J Physiol. 250:1986;H419-25.
22. Lowry OH, Rosenbrough NT, Farr AL, Randall AT. Protein measurements with the Folin Phenol reagent. J Biol Chem. 193:1951;265-275.
23. Pfeffer MA, Braunwald E, Moyé LA, et al. SAVE trial effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial . N Engl J Med. 327:1992;669-677.
24. Sharpe N, Smith H, Murphy J, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1:1988;255-259.
25. Jugdutt BI. Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol. 25:1995;1718-1725.
26. Jugdutt BI, Khan M, Jugdutt SJ, Blinston GE. Combined captopril and isosorbide dinitrate during healing after myocardial infarction effect on ventricular remodeling function, mass and collagen . J Am Coll Cardiol. 25:1995;1089-1096.
27. Kajstura J, Cheng W, Reiss K, Clark WA, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
28. Singal PK, Kirshenbaum LA. A relative deficit in antioxidant reserve may contribute to cardiac failure. Can J Cardiol. 6:1990;47-49.
29. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacol Toxicol Methods. 30:1993;55-67.
30. Kobayashi A, Yamashita T, Kaneko M, Nishiyama T, Hayashi H, Yamazaki N. Effects of verapamil on experimental cardiomyopathy in the bio 14.6 Syrian hamster. J Am Coll Cardiol. 10:1987;1128-1134.
31. Weitz Z, Birnbaum AJ, Sobotka PA, Zarling EJ, Skosey JL. Elevated pentane levels during acute myocardial infarction. Lancet. 337:1991;933-935.
32. Dhaliwal H, Kirshenbaum LA, Randhawa AK, Singal PK. Correlation between antioxidant changes during hypoxia and recovery upon reoxygenation. Am J Physiol. 261:1991;H632-8.
33. Chopra M, Scott N, McMurray J, et al. Captopril a free radical scavenger . Br J Clin Pharmacol. 27:1989;396-399.
34. Vinci JM, Horowitz D, Zusman RM, Pisano JJ, Catt KJ, Keiser HR. The effect of converting enzyme inhibition with SQ20, 881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. Hypertension. 1:1979;416-426.
35. Swartz SL, Williams GH. Angiotensin-converting enzyme inhibition and prostaglandins. Am J Cardiol. 250:1986;F986-90.
36. Colucci WS, Wynee J, Holman BL, Braunwald E. Long term therapy of heart failure with prazosin a randomized double blind trial . Am J Cardiol. 45:1980;337-344.
37. Feldman RC, Ball RM, Winchester MA, Jailon P, Kates R, Harrison D. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure. Am Heart J. 101:1981;534-540.